Solid-nanoemulsion preconcentrate for oral delivery of paclitaxel: Formulation design, biodistribution, and γ scintigraphy imaging

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Ahmad, Javed ^a   Mir, Showkat R ^a   Kohli, Kanchan ^a   Chuttani, Krishna ^b   Mishra, Anil K ^b   Panda, A K ^c   Amin, Saima ^a  

^a HAMDARD UNIVERSITY   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^c NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COSURFACTANT; DIETHYLENE GLYCOL MONOETHYL ETHER; GLYCEROL OLEATE; NANOCARRIER; OCTANOIN; PACLITAXEL; POLYETHYLENE; POLYOXYETHYLENE; POLYOXYL 15 HYDROXYSTEARATE; PROPYLENE GLYCOL; SORBITAN OLEATE; SURFACTANT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG CARRIER; EMULSION; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APPARENT PERMEABILITY; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; EX VIVO STUDY; FEMALE; GAMMA SCINTIGRAPHY; IN VIVO STUDY; INFRARED SPECTROSCOPY; ISOTOPE LABELING; MCF 7 CELL LINE; MTT ASSAY; NANOEMULSION; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; RAT; SOLID NANOEMULSION; SURFACE AREA; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG STABILITY; EMULSION; ILEUM; MEDICINAL CHEMISTRY; METABOLISM; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PROCEDURES; SCINTISCANNING; TISSUE DISTRIBUTION; TOXICITY; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG STABILITY; EMULSIONS; FEMALE; ILEUM; MCF-7 CELLS; NANOPARTICLES; PACLITAXEL; RADIONUCLIDE IMAGING; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 84910019313     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/984756     Document Type: Article

References (39)

1. L. Mei, Z. Zhang, L. Zhao, et al., "Pharmaceutical nanotechnology for oral delivery of anticancer drugs, " Advanced Drug Delivery Reviews, vol. 65, no. 6, pp. 880-890, 2013.
2. S. Feng, L. Zhao, and J. Tang, "Nanomedicine for oral chemotherapy, " Nanomedicine, vol. 6, no. 3, pp. 407-410, 2011.
3. A. K. Singla, A. Garg, and D. Aggarwal, "Paclitaxel and its formulations, " International Journal of Pharmaceutics, vol. 235, no. 1-2, pp. 179-192, 2002.
4. M. Kavallaris, "Microtubules and resistance to tubulin-binding agents, " Nature Reviews Cancer, vol. 10, no. 3, pp. 194-204, 2010.
5. H. Wang, G. Cheng, Y. Du, et al., "Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation, "MolecularMedicine Reports, vol. 7, no. 3, pp. 947-952, 2013.
6. T. N. Ansari, A. Mahmood, B. K. Khattak, S. Rasul, and A. S. Syed, "Toxicity profile and objective response of paclitaxel in metastatic breast cancer, " Journal of the College of Physicians and Surgeons Pakistan, vol. 15, no. 4, pp. 200-203, 2005.
7. C. D. Scripture, W. D. Figg, and A. Sparreboom, "Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives, "CurrentNeuropharmacology, vol. 4, no. 2, pp. 165-172, 2006.
8. K. L. Hennenfent and R. Govindan, "Novel formulations of taxanes: a review. Oldwine in a newbottle?" Annals ofOncology, vol. 17, no. 5, pp. 735-749, 2006.
9. L. Feng and R. J. Mumper, "A critical review of lipid-based nanoparticles for taxane delivery, " Cancer Letters, vol. 334, no. 2, pp. 157-175, 2013.
10. J. Ahmad, K. Kohli, S. R. Mir, and S. Amin, "Lipid based nanocarriers for oral delivery of cancer chemotherapeutics: an insight in the intestinal lymphatic transport, " Drug Delivery Letters, vol. 3, no. 1, pp. 38-46, 2013.
11. J. M. Meerum Terwogt, W. W. Ten Bokkel Huinink, J. H. M. Schellens, et al., "Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel, " Anti-CancerDrugs, vol. 12, no. 4, pp. 315-323, 2001.
12. J. Park, Y. Yan, S. Chi, et al., "Preparation and evaluation of Cremophor-free paclitaxel solid dispersion by a supercritical antisolvent process, " Journal of Pharmacy and Pharmacology, vol. 63, no. 4, pp. 491-499, 2011.
13. V. Bhardwaj, D. D. Ankola, S. C. Gupta, M. Schneider, C. Lehr, and M. N. V. R. Kumar, "PLGA nanoparticles stabilized with cationic surfactant: Safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat, " Pharmaceutical Research, vol. 26, no. 11, pp. 2495-2503, 2009.
14. M. Agüeros, V. Zabaleta, S. Espuelas, M. A. Campanero, and J. M. Irache, "Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles, " Journal of Controlled Release, vol. 145, no. 1, pp. 2-8, 2010.
15. J. S. Choi, B. W. Jo, and Y. C. Kim, "Enhancedpaclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin, " European Journal of Pharmaceutics and Biopharmaceutics, vol. 57, no. 2, pp. 313-318, 2004.
16. Z. Chu, J. S. Chen, C. T. Liau, et al., "Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients, " Anti-Cancer Drugs, vol. 19, no. 3, pp. 275-281, 2008.
17. M. A. Elsheikh, Y. S. Elnaggar, E. Y. Gohar, and O. Y. Abdallah, "Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal, " International Journal of Nanomedicine, vol. 2012, no. 7, pp. 3787-3802, 2012.
18. K. Kohli, S. Chopra, D. Dhar, S. Arora, and R. K. Khar, "Selfemulsifying drug delivery systems: an approach to enhance oral bioavailability, " Drug Discovery Today, vol. 15, no. 21-22, pp. 958-965, 2010.
19. J. Ahmad, K. Kohli, S. R. Mir, and S. Amin, "Self-emulsifying nano carriers for improved oral bioavailability of lipophilic drugs, " Review in Advanced Science and Engineering, vol. 1, no. 2, pp. 134-147, 2012.
20. B. Singh, R. Singh, S. Bandyopadhyay, R. Kapil, and B. Garg, "Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol, " Colloids and Surfaces B: Biointerfaces, vol. 101, pp. 465-474, 2013.
21. B. Tang, G. Cheng, J. Gu, and C. Xu, "Development of solid selfemulsifying drug delivery systems: preparation techniques and dosage forms, " Drug Discovery Today, vol. 13, no. 13-14, pp. 606-612, 2008.
22. M. A. Rahman, Z. Iqbal, and A. Hussain, "Solid nanoemulsion preconcentrate (NanOsorb) for oral delivery of sertraline: development and characterization, " Drug Delivery Letters, vol. 2, no. 4, pp. 231-239, 2012.
23. Y. S. R. Elnaggar, M. A. El-Massik, and O. Y. Abdallah, "Selfnanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization, " International Journal of Pharmaceutics, vol. 380, no. 1-2, pp. 133-141, 2009.
24. J. Ahmad, K. Kohli, S. R. Mir, and S. Amin, "Development and validation of RP-HPLC method for analysis of novel selfemulsifying paclitaxel formulation, " Research and Review: Journal of Pharmaceutical Analysis, vol. 2, no. 3, pp. 17-27, 2013.
25. S. Shafiq-un-Nabi, F. Shakeel, S. Talegaonkar, et al., "Formulation development and optimization using nanoemulsion technique: a technical note, " AAPS PharmSciTech, vol. 8, no. 2, pp. E12-E17, 2007.
26. J. Ahmad, K. Kohli, S. R. Mir, and S. Amin, "Formulation of self-nanoemulsifying drug delivery system for telmisartan with improved dissolution and oral bioavailability, " Journal of Dispersion Science and Technology, vol. 32, no. 7, pp. 958-968, 2011.
27. N. Parmar, N. Singla, S. Amin, and K. Kohli, "Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system, " Colloids and Surfaces B: Biointerfaces, vol. 86, no. 2, pp. 327-338, 2011.
28. P. Li, S. R. Hynes, T. F. Haefele, M. Pudipeddi, A. E. Royce, and A. T. M. Serajuddin, "Development of clinical dosage forms for a poorly water-soluble drug II: Formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug, " Journal of Pharmaceutical Sciences, vol. 98, no. 5, pp. 1750-1764, 2009.
29. S. Singh, S. K. Singh, P. R. Vuddanda, and A. K. Srivastava, "A comparison between use of spray and freeze drying techniques for preparation of solid self-microemulsifying formulation of valsartan and in vitro and in vivo evaluation, " BioMed Research International, vol. 2013, Article ID 909045, 13 pages, 2013.
30. H. Yuan, C. Chen, G. Chai, Y. Du, and F. Hu, "Improved transport and absorption through gastrointestinal tract by pegylated solid lipid nanoparticles, " Molecular Pharmaceutics, vol. 10, no. 5, pp. 1865-1873, 2013.
31. H. J. Yao, R. J. Ju, X. X. Wang, et al., "The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery, " Biomaterials, vol. 32, no. 12, pp. 3285-3302, 2011.
32. M. A. Alam, M. A. Mirza, S. Talegaonkar, A. K. Panda, and Z. Iqbal, "Development of celecoxib complexes: characterization and cytotoxicity studies in MCF-7, " Pharmaceutica Analatica Acta, vol. 4, no. 2, Article ID 1000211, 2013.
33. V. Jain, N. K. Swarnakar, P. R. Mishra, et al., "Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy, " Biomaterials, vol. 33, no. 29, pp. 7206-7220, 2012.
34. K. K. Upadhyay, A. N. Bhatt, E. Castro, et al., "Invitro andinvivo evaluation of docetaxel loaded biodegradable polymersomes, " Macromolecular Bioscience, vol. 10, no. 5, pp. 503-512, 2010.
35. J. Ahmad, K. Kohli, S. R. Mir, and S. Amin, "Quality by design approach for self nanoemulsifying systemfor paclitaxel, " Science of Advanced Materials, vol. 6, pp. 1-14, 2014.
36. V. Bali, M. Ali, and J. Ali, "Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment, " International Journal of Pharmaceutics, vol. 403, no. 1-2, pp. 45-56, 2011.
37. Y. G. Seo, D. H. Kim, T. Ramasamy, et al., "Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system( SNEDDS) for enhanced chemotherapeutic effect, " International Journal of Pharmaceutics, vol. 452, no. 1-2, pp. 412-420, 2013.
38. D. H. Oh, J. H. Kang, D. W. Kim, et al., "Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier, " International Journal of Pharmaceutics, vol. 420, no. 2, pp. 412-418, 2011.
39. P. Zhang, Y. Liu, N. Feng, and J. Xu, "Preparation and evaluation of self-microemulsifying drug delivery system of oridonin, " International Journal of Pharmaceutics, vol. 355, no. 1-2, pp. 269-276, 2008.